Company Quick10K Filing
Applied DNA Sciences
10-Q 2021-03-31 Filed 2021-05-13
10-Q 2020-12-31 Filed 2021-02-11
10-K 2020-09-30 Filed 2020-12-17
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-14
10-Q 2019-12-31 Filed 2020-02-06
10-K 2019-09-30 Filed 2019-12-12
S-1 2019-09-18 Public Filing
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-09
10-Q 2018-12-31 Filed 2019-02-07
10-K 2018-09-30 Filed 2018-12-18
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-05-03
10-Q 2017-12-31 Filed 2018-02-08
10-K 2017-09-30 Filed 2017-12-28
10-Q 2017-06-30 Filed 2017-08-10
10-Q 2017-03-31 Filed 2017-05-11
10-Q 2016-12-31 Filed 2017-02-09
10-K 2016-09-30 Filed 2016-12-06
10-Q 2016-06-30 Filed 2016-08-11
10-Q 2016-03-31 Filed 2016-05-12
10-Q 2015-12-31 Filed 2016-02-10
10-K 2015-09-30 Filed 2015-12-14
10-Q 2015-06-30 Filed 2015-08-10
10-Q 2015-03-31 Filed 2015-05-11
10-Q 2014-12-31 Filed 2015-02-09
10-K 2014-09-30 Filed 2014-12-15
10-Q 2014-06-30 Filed 2014-08-11
10-Q 2014-03-31 Filed 2014-05-12
10-Q 2013-12-31 Filed 2014-02-10
10-K 2013-09-30 Filed 2013-12-20
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-15
10-Q 2012-12-31 Filed 2013-02-14
10-K 2012-09-30 Filed 2012-12-20
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-12-31 Filed 2012-02-14
10-K 2011-09-30 Filed 2011-12-09
10-Q 2011-06-30 Filed 2011-08-10
10-Q 2011-03-31 Filed 2011-05-16
10-Q 2010-12-31 Filed 2011-02-14
10-K 2010-09-30 Filed 2010-12-15
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-10
10-Q 2009-12-31 Filed 2010-02-11
8-K 2021-02-11
8-K 2021-01-19
8-K 2021-01-13
8-K 2021-01-10
8-K 2020-12-17
8-K 2020-10-19
8-K 2020-10-07
8-K 2020-10-02
8-K 2020-09-29
8-K 2020-09-16
8-K 2020-09-15
8-K 2020-08-06
8-K 2020-07-28
8-K 2020-05-14
8-K 2020-05-13
8-K 2020-05-05
8-K 2020-02-06
8-K 2019-12-12
8-K 2019-12-04
8-K 2019-11-21
8-K 2019-11-15
8-K 2019-11-13
8-K 2019-11-07
8-K 2019-10-31
8-K 2019-10-01
8-K 2019-08-22
8-K 2019-08-13
8-K 2019-08-06
8-K 2019-07-30
8-K 2019-07-16
8-K 2019-05-16
8-K 2019-05-09
8-K 2019-03-28
8-K 2019-02-07
8-K 2019-01-29
8-K 2019-01-25
8-K 2018-12-26
8-K 2018-12-21
8-K 2018-12-13
8-K 2018-12-06
8-K 2018-11-29
8-K 2018-09-20
8-K 2018-08-31
8-K 2018-08-13
8-K 2018-05-03
8-K 2018-03-31
8-K 2018-02-27
8-K 2018-02-08

Applied DNA Sciences Financials

APDN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash122,7471,9368571,2567259844,4061,8326,3604,1991,9882,0261,3932,87298410,7307,31212,3839,7867,0874,4796,7024,0202,4032,9604,7653,7092,5151,6603,1381,541507559
Accounts Receivable1782092333244432973624085886737496065188351,1151,1602,0783,9303,9245,0274,7926,3756,1565,1924,7462,5882,1561,5261,4151,486615316244840
Inventory127298323354377326314294295221225315310143
PP&E089821213664634634931,0021,1061,2081,2231,3151,3355215885271,4255628798062,0567246725902,1905005515362,4563693162652,519
Assets8943,5042,5221,4521,9701,3491,6255,0733,8418,3756,2413,7823,7713,5065,0223,62714,12315,55420,48517,71215,21915,56616,77013,21710,4238,1549,6097,9346,6085,6346,1494,2262,9853,565
Accounts Payable2144736036851,2496417709869051,0608869987701,2381,5991,9091,4791,5301,6581,1581,0163836024393875019446428391,152
Long-Term Debt2500320
Liabilities4,4993,8766386545928,3238,8441,5333,7594,3584,1033,4604,9751,7211,6711,6232,9872,4892,6843,0335,2004,5883,9262,4051,2961,4702,2263,5504,8795,3834,9604,7744,413
Stockholders' Equity-995-1,3548141,316757-6,698-3,7712,3084,6161,882-320311-1,4683,3011,95512,50012,56717,99615,02812,18610,36512,1829,2918,0186,8588,1385,7073,058755766-734-1,789-841
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2302815175185292913183456457295976378416461,2421,5192,2683,9801,3245736531,6369039051,7978476481,0441,0161,1958847782,0531,673
Cost of Revenue121442275297232273331372253251153133271320
Gross Profit5321,1946286081,5655743166727649457316451,7831,353
R&D4810778961001581481761851834593602662152783733106744727291,078832519636603525740670625717710651720887
SG&A1,5813,8602,1521,8251,7531,8862,5212,7543,2412,6823,8463,2982,9483,1564,6712,9013,5083,6583,5543,1202,7072,6233,9013,2303,4032,7902,5931,9972,8823,5723,0822,5292,4072,260
Tax00000000000000000000000000000000015
Net Income-2,155-2,410-1,544-1,430-1,767-8,705-3,128-2,136-3,718-6,292-2,750-1,919-2,106-7,829-1,886-1,671-496-2,926-3,468-3,367-2,415-3,961-3,429-2,611-2,855-3,184-2,146-2,888-3,475-3,234-2,687-1,478-1,224
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-812-1,032-1,124-993-1,740-2,149-1,808-2,173-2,066-2,196-2,008-2,242-2,356-1,616-1,255-1,739-2,721-2,503-2,227-2,446-2,069-2,630-1,866-914-2,573-707-2,509-1,514-2,288-1,283-1,777
Cash Investing0-47-19-970-30-768-423-95-15-100-20-31-202-227-1,679-66-94-472-147-43-51-18-34-48-1554-52-12-41
Cash Financing5582,0005,60027,12501,6293,865-7011,22807,85800-144,33402661,5054,426-1931,6503,0447042541,827